Navigation Links
Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr

Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy Laboratories on a preferential basis for Rs 20 crore. //

The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shareholders' approval, the company informed the Bombay Stock Exchange.

The board also approved the allotment of shares over 1.11 crore equity shares to the erstwhile shareholders of Credence Pharmaceuticals (50.07 lakh shares) and Hemarus Healthcare (61. 20 lakh equity shares) pursuant to the Scheme of amalgamation entered between Credence and Hemarus Healthcare with the company, it said.

The scheme had been approved by the High Court of Andhra Pradesh at Hyderabad in its order dated May 02, 2006, it added.

The Extra Ordinary General Meeting will be held on August 10 to seek the shareholder's approval for the above proposal.

Zenotech's shares closed at Rs 72, up 1.69 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
2. Unsatisfactory Grade On Womens Health Issues
3. Who Board To Discuss Asian Tsunami Related Health Issues
4. WHO Issues Caution Against Bird Flu Epidemic
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
7. High Court Issues Notice To Centre On Smoking Ban In Films
8. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
9. China Issues New Legislation To Ban Human Organ Trade
10. Court Issues Order NACO On Gay Issue
11. NGOs and Various Groups Come Together To Address the Issues on AIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... ... is expanding its educational offerings of corporate finance programs to address the increasingly ... program, will help executives increase their knowledge of sophisticated corporate finance and will ...
(Date:3/30/2017)... ... March 30, 2017 , ... ... Academy of Nutrition and Dietetics (AND), will join nonprofit Seafood Nutrition Partnership (SNP) ... a live webinar designed to help nutrition educators and students inform consumers about ...
(Date:3/29/2017)... ... March 29, 2017 , ... During the last week ... free screening colonoscopies to eligible individuals in the local community. , Colon cancer ... regular screenings can detect colon cancer while it is small, confined and easier to ...
(Date:3/29/2017)... NY (PRWEB) , ... March 29, 2017 , ... ... men’s and women’s professional squash, announced it has enlisted New York City-based sports ... The agency will develop and procure sponsorship opportunities for the Professional Squash Association ...
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC TITLE ... the official title sponsor of the Baltimore Women’s Classic, the largest all women’s 5K ... walk or run the course around the Baltimore Inner Harbor. Mercy has been the ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... March 30, 2017  Lannett Company, Inc. (NYSE: ... made a $25 million payment against its existing revolving ... combined with the $75 million payment we made earlier ... million in annualized cash interest expense, at current rates" ... Lannett.  "Our business is solid and we continue to ...
(Date:3/30/2017)... March 30, 2017 Revenue Prospects by Product ... and COPD) and Geography Respiratory Inhalers - our new ... the Respiratory Inhalers market heading? If you are involved in this ... report shows you the potential revenues streams to 2027, assessing data, ... ...
(Date:3/30/2017)... Julie & Lefkowitz LLP, a class action law firm dedicated ... fiduciary duty claim involving the board of directors of Synergy ... If you are a shareholder of Synergy Pharmaceuticals and are ... charge, please visit us at: ... http://pjlfirm.com/synergy-pharmaceuticals-inc/ ...
Breaking Medicine Technology: